It was shown that wtp53 inhibits CD44 expression in breast cancer cells, but R248H mutp53 increased CD44+ cells in colorectal cancer (Zeilstra et al., 2013; Solomon et al., 2018). This evidence concerns the gene CD44 and breast carcinoma.